Home
Matthew Gline, CEO: Roivant Sciences ROIV Sell · Filed 25/12/17
Trade details
- Type
- Insider sale
- Amount
- $12,273,394.88
- Shares · price
- 566,116 sh · $21.68 a share
- Held after
- 18,084,676 sh
- Person
- Matthew GlineCEO
- Trade date
- 25/12/15
- Filed
- 25/12/17
- Days to filing
- 2 days
Sold 3.0% of holdings
- Share of holding sold
- 3.0%
Roivant Sciences trades, last 26 weeks
What else happened in Roivant Sciences around then
Filed or reported within 30 days of the trade day · 25/11/15~01/14Matthew Gline's recent trades
- Matthew Gline
SellRoivant Sciences
SellRoivant Sciences
ROIV
$8.4M
289,774 sh
$8.4M
Filed 04/20
Traded 04/16
- Matthew Gline
Planned saleRoivant Sciences
Planned saleRoivant Sciences
ROIV
$8.4M
289,774 sh
$8.4M
Filed 04/16
Traded 04/16
- Matthew Gline
SellRoivant Sciences
SellRoivant Sciences
ROIV
$20.5M
943,527 sh
$20.5M
Filed 25/12/17
Traded 25/12/15
- Matthew Gline
SellRoivant Sciences
SellRoivant Sciences
ROIV
$5M
230,357 sh
$5M
Filed 25/12/17
Traded 25/12/15
- Matthew Gline
Planned saleRoivant Sciences
Planned saleRoivant Sciences
ROIV
$37.7M
1,740,000 sh
$37.7M
Filed 25/12/15
Traded 25/12/15